Literature DB >> 19850309

Preliminary report: hepatic fat and inflammation in type 2 diabetes mellitus.

Aramesh Saremi1, Matthew Allison, Dominic Ditomasso, Ling Ge, Robert Anderson, Tom E Moritz, William Duckworth, Carlos Abraira, Peter D Reaven.   

Abstract

Although the association between inflammation and hepatic fat is fairly established, it remains unclear whether this association is independent of general measures of obesity and standard cardiovascular risk factors. Therefore, the aim of this study was to investigate the contribution of hepatic steatosis as an independent predictor of chronic inflammation in 281 subjects with type 2 diabetes mellitus. Reduced hepatic steatosis significantly (P < .01) correlated with C-reactive protein (r = -0.16) and adiponectin (r = 0.23). The association of hepatic steatosis with both C-reactive protein and adiponectin remained significant after adjustment for age, ethnicity, body mass index (or waist circumference), triglycerides, high-density lipoprotein, and total cholesterol. These data support the concept that accumulation of hepatic fat is related to enhanced inflammation in type 2 diabetes mellitus independent of general measures of obesity and standard cardiovascular risk factors. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19850309      PMCID: PMC2823936          DOI: 10.1016/j.metabol.2009.07.041

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  11 in total

1.  Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation.

Authors:  M Raquel Oliva; Koenraad J Mortele; Enrika Segatto; Jonathan N Glickman; Sukru Mehmet Erturk; Pablo R Ros; Stuart G Silverman
Journal:  J Comput Assist Tomogr       Date:  2006 Jan-Feb       Impact factor: 1.826

2.  Gene expression in human NAFLD.

Authors:  Dario Greco; Anna Kotronen; Jukka Westerbacka; Oscar Puig; Perttu Arkkila; Tuula Kiviluoto; Saara Laitinen; Maria Kolak; Rachel M Fisher; Anders Hamsten; Petri Auvinen; Hannele Yki-Järvinen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-04-03       Impact factor: 4.052

3.  Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes.

Authors:  P D Reaven; J Sacks
Journal:  Diabetologia       Date:  2005-02-02       Impact factor: 10.122

4.  Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.

Authors:  Dongsheng Cai; Minsheng Yuan; Daniel F Frantz; Peter A Melendez; Lone Hansen; Jongsoon Lee; Steven E Shoelson
Journal:  Nat Med       Date:  2005-01-30       Impact factor: 53.440

5.  Relationship between the serum concentrations of C-reactive protein and parameters of adiposity and insulin resistance in patients with type 2 diabetes mellitus.

Authors:  Tomoyuki Iwasaki; Atsushi Nakajima; Masato Yoneda; Yasuo Terauchi
Journal:  Endocr J       Date:  2006-05-20       Impact factor: 2.349

6.  Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.

Authors:  Masato Yoneda; Tomoyuki Iwasaki; Koji Fujita; Hiroyuki Kirikoshi; Masahiko Inamori; Yuichi Nozaki; Shiro Maeyama; Koichiro Wada; Satoru Saito; Yasuo Terauchi; Atsushi Nakajima
Journal:  Alcohol Clin Exp Res       Date:  2007-01       Impact factor: 3.455

7.  Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study.

Authors:  Ryan L McKimmie; Kurt R Daniel; J Jeffrey Carr; Donald W Bowden; Barry I Freedman; Thomas C Register; Fang-Chi Hsu; Kurt K Lohman; Richard B Weinberg; Lynne E Wagenknecht
Journal:  Am J Gastroenterol       Date:  2008-10-03       Impact factor: 10.864

8.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

9.  Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes.

Authors:  Swati Joshi-Barve; Shirish S Barve; Kiranmayi Amancherla; Leila Gobejishvili; Daniell Hill; Matthew Cave; Prachi Hote; Craig J McClain
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

10.  Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.

Authors:  Carlos Abraira; William Duckworth; Madeline McCarren; Nicholas Emanuele; Danielle Arca; Domenic Reda; William Henderson
Journal:  J Diabetes Complications       Date:  2003 Nov-Dec       Impact factor: 2.852

View more
  2 in total

1.  Cyclocarya paliurus Triterpenoids Improve Diabetes-Induced Hepatic Inflammation via the Rho-Kinase-Dependent Pathway.

Authors:  Cuihua Jiang; Yiting Wang; Qiaomei Jin; Dongjian Zhang; Meng Gao; Nan Yao; Zhiqi Yin; Jian Zhang; Shiping Ma
Journal:  Front Pharmacol       Date:  2019-07-25       Impact factor: 5.810

2.  Metformin in Combination with Malvidin Prevents Progression of Non-Alcoholic Fatty Liver Disease via Improving Lipid and Glucose Metabolisms, and Inhibiting Inflammation in Type 2 Diabetes Rats.

Authors:  Wenlan Zou; Chen Zhang; Xuefang Gu; Xiaohong Li; Huiming Zhu
Journal:  Drug Des Devel Ther       Date:  2021-06-17       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.